PDGFRB is overexpressed in metastatic medulloblastoma

Nature Genetics

Volumn 35, Issue 3, 2003, Pages 197-198

  Gilbertson, Richard J ^a   Clifford, Steven C ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

BRAIN TUMOR; GENE EXPRESSION; HUMAN; LETTER; MEDULLOBLASTOMA; METASTASIS; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

BRAIN NEOPLASMS; HUMANS; MEDULLOBLASTOMA; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RNA, MESSENGER;

EID: 0242361321     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1103-197     Document Type: Letter

References (2)

1. MacDonald, T.J. et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat. Genet. 29, 143-152 (2001).
2. Ellison, D.W., Clifford, S.C., Gajjar, A. & Gilbertson, R.J. What's new in neuro-oncology? Recent advances in medulloblastoma. Eur. J. Paediatr. Neurol. 7, 53-66 (2003).